U.S. Markets closed

G1 Therapeutics aims to expand as it approaches NDA filing

Seth Thomas Gulledge
G1 Therapeutics aims to expand as it approaches NDA filing

Sailing toward a new drug application on a wave of positive data and skyrocketing stocks, one Triangle public company says it will also be bringing more hands on board.